✦ LIBER ✦

MP-03.07 Cost/Benefit of Incorporating Circulating Prostate Cell Detection in a Screening Programme for Prostate Cancer

✍ Scribed by N. Murray; E. Reyes; N. Orellana; A. Andrusco

Book ID: 116953839
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 142 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.07.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-03.08 Incorporating Circulating Prost

MP-03.08 Incorporating Circulating Prostate Cell Detection in a Screening Programme for Prostate Cancer Does not Detect Low Grade Small Volume Tumours

✍ N. Murray; E. Reyes; N. Orellana; A. Andrusco 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 142 KB

MP-4.03: P504S Expressing Prostate Cells

MP-4.03: P504S Expressing Prostate Cells in Blood of Healthy Men: A Possible Screening Test for Prostate Cancer

✍ N. Murray; S. Santos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

MP69-07 BENEFITS AND HARMS OF DUTASTERID

MP69-07 BENEFITS AND HARMS OF DUTASTERIDE FOR PROSTATE CANCER IN THE RE-BIOPSY POPULATION FOR YEARS 1-2: A RE-ANALYSIS OF REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

✍ Mir, Maria Carmen; Li, Jianbo; Kattan, Michael; Jones, J.S.; Stephenson, Andrew 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

PIII-03 MORTALITY BENEFIT OF SCREENING M

PIII-03 MORTALITY BENEFIT OF SCREENING MEN WITH A FAMILY HISTORY OF PROSTATE CANCER AS A SURROGATE FOR HIGH GENETIC RISK IN THE PLCO TRIAL

✍ Liss, Michael; Hemal, Sij; Krane, Spencer; Kader, A. Karim 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 116 KB

MP-03.13 Every Three Years PSA Screening

MP-03.13 Every Three Years PSA Screening is Sufficient to Detect Almost All Prostate Cancers While Still Curable in Men With Baseline PSA Less Than 2.1ng/mL: Findings of a Longitudinal Study in Natori, Japan

✍ S. Kawamura; T. Tochigi; M. Kuwahara 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB